UOC
BSX icon

UBS O'Connor’s Boston Scientific BSX Stock Holding History

UBS O'Connor’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,334
Closed -$744K – 355
2024
Q4 		$744K Buy
8,334
+1,507
+22% +$133K 0.02% 255
2024
Q3 		$572K Sell
6,827
-273
-4% -$21.5K 0.01% 335
2024
Q2 		$547K Sell
7,100
-7,700
-52% -$564K 0.02% 360
2024
Q1 		$1.01M Sell
14,800
-4,985
-25% -$321K 0.03% 273
2023
Q4 		$1.14M Sell
19,785
-31,607
-62% -$1.69M 0.04% 251
2023
Q3 		$2.71M Buy
51,392
+10,000
+24% +$524K 0.05% 189
2023
Q2 		$2.24M Sell
41,392
-4,616
-10% -$241K 0.05% 273
2023
Q1 		$2.3M Sell
46,008
-9,809
-18% -$462K 0.05% 293
2022
Q4 		$2.58M Sell
55,817
-14,188
-20% -$614K 0.05% 347
2022
Q3 		$2.71M Sell
70,005
-63,000
-47% -$2.53M 0.03% 470
2022
Q2 		$4.96M Buy
133,005
+65,476
+97% +$2.67M 0.05% 331
2022
Q1 		$2.99M Buy
+67,529
New +$2.93M 0.03% 431
2015
Q1 		– Sell
-24,302
Closed -$322K – 767
2014
Q4 		$322K Buy
+24,302
New +$311K 0.01% 538

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS O'Connor's BSX Position: Q1 2025 in Review

UBS O'Connor sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 8,334 shares — an estimated $744K sold.

UBS O'Connor first reported a position in BSX in Q4 2014 and held it in 13 quarters. The position peaked at $4.96M in Q2 2022. 1,650 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • UBS O'Connor reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 8,334 Boston Scientific shares in Q1 2025, an estimated $744K.
  • UBS O'Connor first reported a position in Boston Scientific in Q4 2014 and held it in 13 quarters.
  • UBS O'Connor's Boston Scientific position peaked at $4.96M in Q2 2022.
  • 1,650 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.